FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to the antibody to TSLP-receptor. What is also disclosed is an expression vector, a host cell for producing said antibody. Disclosed is a method of producing said antibody.
EFFECT: invention is capable of effectively treating diseases associated with TSLP-receptor.
8 cl, 7 ex, 5 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY TO HUMAN CD73 | 2017 |
|
RU2754058C2 |
| THERAPEUTIC BINDING MOLECULES | 2002 |
|
RU2328506C2 |
| ANTI-CD3-ANTIBODY AND MOLECULE CONTAINING THIS ANTIBODY | 2017 |
|
RU2790326C2 |
| MONOCLONAL ANTIBODY TO IL-5RΑ | 2017 |
|
RU2698048C2 |
| THYMIC STROMAL LYMPHOPOIETIN RECEPTOR ANTIBODIES | 2007 |
|
RU2486202C2 |
| RECOMBINANT YEAST TRANSFORMANT AND METHOD FOR OBTAINING WITH ITS USE OF Fc-FRAGMENT OF IMMUNOGLOBULIN | 2014 |
|
RU2664862C2 |
| MONOCLONAL ANTIBODIES AND METHODS OF USING THEM | 2017 |
|
RU2694412C2 |
| AFFINITY-MATURED HUMANISED ANTI-CEA MONOCLONAL ANTIBODIES | 2010 |
|
RU2570554C2 |
| MONOCLONAL ANTIBODIES WHICH SPECIFICALLY BIND TO THE BETA-CHAIN REGION OF THE TRBV-9 FAMILY OF THE HUMAN T-CELL RECEPTOR, AND METHODS FOR USE THEREOF | 2018 |
|
RU2711871C1 |
| CONSTRUCTED ANTI-TSLP ANTIBODY | 2010 |
|
RU2575039C2 |
